CRYO CELL INTERNATIONAL INC

For the period ended Feb 29, 2024. Filed Apr 15, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Feb 29, 2024 · Filed Apr 15, 2024

CCEL$4.87-0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Income

	For the Three Months Ended
	February 29,	February 28,
	2024	2023
Revenue:
Processing and storage fees	$7,805,522	$7,561,518
Public banking revenue	43,713	230,697
Product revenue	3,000	32,200
Total revenue	7,852,235	7,824,415
Costs and Expenses:
Cost of sales	2,160,468	2,067,364
Selling, general and administrative expenses	4,339,645	3,878,903
Change in fair value of contingent consideration	(5,176)	(164,701)
Research, development and related engineering	502,889	78,834
Depreciation and amortization	33,186	280,844
Total costs and expenses	7,031,012	6,141,244
Operating Income	821,223	1,683,171
Other Income (Expense):
Gains (losses) on marketable securities	274,971	(3,681)
Loss on interest rate swap	(45,288)	—
Other income	63	1,268
Interest expense	(256,459)	(466,231)
Total other income (expense)	(26,713)	(468,644)
Income before income tax expense	794,510	1,214,527
Income tax expense	(238,269)	(447,715)
Net income	$556,241	$766,812
Net income per common share - basic	$0.07	$0.09
Weighted average common shares outstanding - basic	8,277,844	8,467,074
Net income per common share - diluted	$0.07	$0.09
Weighted average common shares outstanding - diluted	8,325,027	8,474,737

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.